- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- September 2023
- 160 Pages
Global
From €3276EUR$3,599USD£2,782GBP
- Report
- January 2023
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- October 2021
- 137 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- May 2023
- 92 Pages
Global, Africa, Middle East Global, Africa, Middle East
From €3500EUR$4,119USD£3,077GBP
- Book
- February 2024
- 640 Pages
- Book
- October 2019
- 632 Pages
- Book
- January 2016
- 368 Pages
- Book
- May 2013
- 400 Pages
- Book
- April 2012
- 1272 Pages
- Book
- July 2024
North America
- Book
- May 2024
North America

Gastrointestinal cancer is a type of cancer that affects the digestive system, including the stomach, small intestine, colon, rectum, liver, gallbladder, pancreas, and bile ducts. It is the most common type of cancer in the world, and is the second leading cause of cancer-related deaths. Gastroenterology is the branch of medicine that focuses on the diagnosis and treatment of diseases of the digestive system. Gastroenterologists are often the first line of defense in diagnosing and treating gastrointestinal cancer.
Gastrointestinal cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. In some cases, targeted therapies, such as immunotherapy, may be used. The prognosis for gastrointestinal cancer depends on the stage of the cancer, the type of cancer, and the patient's overall health.
There are many companies in the gastrointestinal cancer market, including AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies develop and market drugs and treatments for gastrointestinal cancer, as well as provide support services for patients and their families. Show Less Read more